MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines
- 28 July 2011
- journal article
- research article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 32 (6) , 355-367
Abstract
Several noncoding microRNAs (miR or miRNA) have been shown to regulate the expression of drug‐metabolizing enzymes and transporters. Xenobiotic drug‐induced changes in enzyme and transporter expression may be associated with the alteration of miRNA expression. Therefore, this study investigated the impact of 19 xenobiotic drugs (e.g. dexamethasone, vinblastine, bilobalide and cocaine) on the expression of ten miRNAs (miR‐18a, ‐27a, ‐27b, ‐124a, ‐148a, ‐324‐3p, ‐328, ‐451, ‐519c and −1291) in MCF‐7, Caco‐2, SH‐SY5Y and BE(2)‐M17 cell systems. The data revealed that miRNAs were differentially expressed in human cell lines and the change in miRNA expression was dependent on the drug, as well as the type of cells investigated. Notably, treatment with bilobalide led to a 10‐fold increase of miR‐27a and a 2‐fold decrease of miR‐148a in Caco‐2 cells, but no change of miR‐27a and a 2‐fold increase of miR‐148a in MCF‐7 cells. Neuronal miR‐124a was generally down‐regulated by psychoactive drugs (e.g. cocaine, methadone and fluoxetine) in BE(2)‐M17 and SH‐SY5Y cells. Dexamethasone and vinblastine, inducers of drug‐metabolizing enzymes and transporters, suppressed the expression of miR‐27b, ‐148a and −451 that down‐regulate the enzymes and transporters. These findings should provide increased understanding of the altered gene expression underlying drug disposition, multidrug resistance, drug–drug interactions and neuroplasticity. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 56 references indexed in Scilit:
- MicroRNAs Regulate CYP3A4 Expression via Direct and Indirect TargetingDrug Metabolism and Disposition, 2009
- Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer CellsCancer Research, 2009
- Epigenetic and MicroRNA-Dependent Control of Cytochrome P450 Expression: A Gap Between DNA and ProteinPharmacogenomics, 2009
- MicroRNA regulates human vitamin D receptorInternational Journal of Cancer, 2009
- MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer CellsMolecular Pharmacology, 2009
- MicroRNA-18a Prevents Estrogen Receptor-α Expression, Promoting Proliferation of Hepatocellular Carcinoma CellsGastroenterology, 2009
- MicroRNA 18 and 124a Down-Regulate the Glucocorticoid Receptor: Implications for Glucocorticoid Responsiveness in the BrainEndocrinology, 2009
- Bioactive Terpenoids and Flavonoids from Ginkgo Biloba Extract Induce the Expression of Hepatic Drug-Metabolizing Enzymes Through Pregnane X Receptor, Constitutive Androstane Receptor, and Aryl hydrocarbon Receptor-Mediated PathwaysPharmaceutical Research, 2008
- Dexamethasone down-regulates ABCG2 expression levels in breast cancer cellsBiochemical and Biophysical Research Communications, 2008
- Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cellsBiochemical Pharmacology, 2008